Global Markets Directs, conoGenetix biosciences GmbH Product Pipeline Review 2015, provides an overview of the conoGenetix biosciences GmbHs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of conoGenetix biosciences GmbHs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope The report provides brief overview of conoGenetix biosciences GmbH including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of conoGenetix biosciences GmbHs human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the conoGenetix biosciences GmbHs pipeline products Reasons to buy Evaluate conoGenetix biosciences GmbHs strategic position with total access to detailed information on its product pipeline Assess the growth potential of conoGenetix biosciences GmbH in its therapy areas of focus Identify new drug targets and therapeutic classes in the conoGenetix biosciences GmbHs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

1. conoGenetix biosciences GmbH - Product Pipeline Review - 2015
Global Markets Directs, conoGenetix biosciences GmbH Product Pipeline Review 2015, provides an overview of the conoGenetix biosciences GmbHs
pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of conoGenetix biosciences GmbHs, complete with
comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It
also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides brief overview of conoGenetix biosciences GmbH including business description, key information and facts, and its locations and
subsidiaries The report reviews current pipeline of conoGenetix biosciences GmbHs human therapeutic division and enlists all their major and minor projects The
report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest
company statement Latest news and deals relating to the conoGenetix biosciences GmbHs pipeline products Reasons to buy
Evaluate conoGenetix biosciences GmbHs strategic position with total access to detailed information on its product pipeline Assess the growth potential of
conoGenetix biosciences GmbH in its therapy areas of focus Identify new drug targets and therapeutic classes in the conoGenetix biosciences GmbHs R&D
portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill
portfolio gaps Develop strategic initiatives by understanding the focus areas of conoGenetix biosciences GmbH and exploit collaboration and partnership
opportunities Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan
mergers and acquisitions effectively by identifying the most promising pipeline of conoGenetix biosciences GmbH Develop and design in-licensing and
out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Explore the
dormant and discontinued projects of conoGenetix biosciences GmbH and identify potential opportunities in those areas Avoid Intellectual Property Rights
related issues
table Of Contents
table Of Contents 2
list Of Tables 3
list Of Figures 3
conogenetix Biosciences Gmbh Snapshot 4
conogenetix Biosciences Gmbh Overview 4
key Information 4
key Facts 4
conogenetix Biosciences Gmbh - Research And Development Overview 5
key Therapeutic Areas 5
conogenetix Biosciences Gmbh - Pipeline Review 6
pipeline Products By Stage Of Development 6
pipeline Products - Monotherapy 7
conogenetix Biosciences Gmbh - Pipeline Products Glance 8
conogenetix Biosciences Gmbh - Early Stage Pipeline Products 8
preclinical Products/combination Treatment Modalities 8
discovery Products/combination Treatment Modalities 9
conogenetix Biosciences Gmbh - Drug Profiles 10
cgtx-a 10
product Description 10
mechanism Of Action 10
r&d Progress 10
cgtx-f 11
product Description 11
mechanism Of Action 11
r&d Progress 11
cgtx-g 12
product Description 12
mechanism Of Action 12
r&d Progress 12
synthetic Peptide To Block Potassium Voltage-gated Channel Subfamily A Member 3 (kv1.3) For Autoimmune Disorders 13
product Description 13
mechanism Of Action 13
conoGenetix biosciences GmbH - Product Pipeline Review - 2015

2. r&d Progress 13
conogenetix Biosciences Gmbh - Pipeline Analysis 14
conogenetix Biosciences Gmbh - Pipeline Products By Target 14
conogenetix Biosciences Gmbh - Pipeline Products By Molecule Type 15
conogenetix Biosciences Gmbh - Pipeline Products By Mechanism Of Action 16
conogenetix Biosciences Gmbh - Locations And Subsidiaries 17
head Office 17
appendix 18
methodology 18
coverage 18
secondary Research 18
primary Research 18
expert Panel Validation 18
contact Us 18
disclaimer 19
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
conoGenetix biosciences GmbH - Product Pipeline Review - 2015